BILL posts stronger Q4 revenue, profit growth but sees slower FY27; stock gains
BILL posts stronger Q4 revenue, profit growth but sees slower FY27; stock gains
Clene at Emerging Growth Conference: FDA path takes shape for ALS drug
Clene at Emerging Growth Conference: FDA path takes shape for ALS drug